Shaper Capital focuses on building transformative businesses, particularly in data and middleware, by identifying and cultivating exceptional talent. They operate with an active, hands-on strategy, often acting as co-founders and taking significant stakes rather than being passive investors.
67% of their portfolio is in Healthcare. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Their most common stage is series-a (67% of deals). Average disclosed round size is $24.2M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$91.7M
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Protege | Series A | $30M | Aug 2025 |
 Arbital Health | Series B | $31M | Jul 2025 |
| NNextSense | Series A | $11.5M | Dec 2024 |
Top Co-Investors
ETF partners1 shared
Edge1 shared
Timeless1 shared
Valtruis1 shared
Transformation Capital1 shared
Andreessen Horowitz1 shared
Footwork1 shared
CRV (Charles River Ventures)1 shared
Bloomberg Beta1 shared
Flex1 shared
Liquid 2 Ventures1 shared
Last updated: 21 April 2026